Hypersensitivity pneumonitis

Changed by Daniel J Bell, 5 Jul 2021

Updates to Article Attributes

Body was changed:

Hypersensitivity pneumonitis, previously known as extrinsic allergic alveolitis, represents a group of immune-mediated pulmonary disorders characterised by an inflammatory and/or fibrotic reaction affecting the lung parenchyma and small airways.

Its diagnosis relies on a constellation of findings: exposure to an offending antigen, characteristic signs and symptoms, abnormal chest findings on physical examination, and abnormalities on pulmonary function tests and radiographic evaluation. 

Terminology

Hypersensitivity pneumonitis can be categorised into two subtypes 13,14:

  • non-fibrotic hypersensitivity pneumonitis
  • fibrotic hypersensitivity pneumonitis

In patients where an inhaled antigen exposure has not been identified the terms cryptogenic hypersensitivity pneumonitis or hypersensitivity pneumonitis of undetermined cause have been used 14.

Previously, hypersensitivity pneumonitis had been categorised into 5

although this is no longer in favour given the difficulty in delineating between these particular subtypes 14.

Epidemiology

Incidence varies widely based on climate, geography, and occupational or environmental exposures although is estimated at ~0.6 (range 0.3-0.9) per 100,000 population 14.

Clinical presentation

The onset of symptoms may be acute (weeks-months) or can be insidious (month-to-years of gradually worsening symptoms) 14. Common symptoms include dyspnoea and cough with less common symptoms being weight loss, fever/chills, malaise, chest tightness and wheezing 14.

Clinical examination may demonstrate mid-inspiratory squeaks and finger clubbing. There is a restriction pattern with decreased diffusing capacity on pulmonary function tests 3,14

Pathology

Aetiology

More than 200 different antigens have been associated with the development of hypersensitivity pneumonitis. Antigen exposure may be domestic, industrial and/or recreational and there may be more than one antigen exposure 14:

  • microbes
    • fungi/moulds, e.g. mushrooms, Aspergillus, Cryptococcus
    • yeasts, e.g. candida
    • bacteria, e.g. Pseudomonas
    • protozoa, e.g. Amoebae
    • nematodes
    • mites, e.g. Acarus siro
  • proteins
    • animal proteins, e.g. animal fur dust, avian droppings/feathers
    • plant proteins, e.g. wood particles, grain flour
  • inorganic particular matter
    • chemicals, e.g. isocyanate found in paint hardener
    • pharmaceuticals, e.g. antibiotics such as penicillin, immunosuppressants such as sirolimus/everolimus 8
    • metals, e.g. cobalt, zinc

The triggering particles are usually in the range of 1-5 micrometres in size 5. In ~40% (range 30-50%) the inciting agent may not be identified 14.

Depending on the type of precipitant, numerous other more precipitant-specific clinical terms have been used such as:

Microscopic appearance

The histopathologic process consists of chronic inflammation of the bronchi and peribronchiolar tissue, often with poorly defined granulomas and giant cells in the interstitium or alveoli. Fibrosis and emphysema may develop later on.

Most cases of hypersensitivity pneumonitis, whether acute or insidious, include the following four histologic features in variable amounts and combinations 3.

  • cellular bronchiolitis: chronic inflammatory cells lining the small airways, sometimes with resultant epithelial ulceration
  • diffuse chronic interstitial inflammatory infiltrates: primarily consisting of lymphocytes and plasma cells but often including eosinophils, neutrophils, and mast cells
  • poorly circumscribed interstitial non-necrotising (non-caseating) granulomas: consisting of lymphocytes, plasma cells, and epithelioid histiocytes, with or without giant cells
  • individual giant cells in the alveoli or interstitium

Smoking is protective against hypersensitivity pneumonitis, presumably by the inhibitory action of nicotine on macrophage activation and lymphocyte proliferation and function 9. However, when smokers do develop hypersensitivity pneumonitis, it is more commonly fibrosing disease with a worse prognosis 10.

Subtypes

Hypersensitivity pneumonitis can be categorised into two subtypes based on the absence/presence of fibrosis given this is a determining factor in prognosis 13,14:

  • non-fibrotic hypersensitivity pneumonitis: purely inflammatory
  • fibrotic hypersensitivity pneumonitis: mixed inflammatory/fibrotic or purely fibrotic

Radiographic features

HRCT chest is the main imaging technique for hypersensitivity pneumonitis with the various features for each subtype being able to be described as 14:

  • typical hypersensitivity pneumonitis
  • compatible with hypersensitivity pneumonitis
  • indeterminate for hypersensitivity pneumonitis when features of the above two are absent
Plain radiograph

In population-based studies, the sensitivity of chest radiography for detection of this disease is relatively low 1. Many patients may indeed have normal radiographs 3

Abnormal plain radiographic findings may be observed in some patients can include 3

  • numerous poorly defined small (<5 mm) opacities throughout both lungs, sometimes with sparing of the apices and bases
  • airspace disease: usually seen as ground-glass opacities (can be patchy or diffuse, resembling pulmonary oedema) or, more rarely, as consolidation
  • a pattern of fine reticulation may also occur
  • zonal distribution is variable from patient to patient and may even show temporal variation within the same patient

Later stages

  • when fibrosis develops: there may be a reticular pattern and honeycombing, which sometimes are more severe in the upper lobes than in the lower ones
  • volume loss may occur: particularly in the upper lungs, and peribronchial thickening may be visible
  • cardiomegaly may develop as a result of cor pulmonale
CT
Non-fibrosing hypersensitivity pneumonitis
Fibrosing hypersensitivity pneumonitis

Other associated features of both subtypes include ref:

  • small volume mediastinal lymphadenopathy (generally 10-20 mm in short-axis diameter) 
  • occasional pulmonary arterial enlargement
  • centrilobular emphysema
  • with developing fibrosis, there can be reticulation, mainly in the middle portion of the lungs or fairly evenly throughout the lungs but with relative sparing of the extreme apices and bases

Treatment and prognosis

Removal of the precipitant is often the key to management.

Differential diagnosis

Due to a variable radiographic presentation, it may not be meaningful to give a differential diagnosis for hypersensitivity pneumonitis per se. It is better to refer to the differential for a particular radiographic feature:

  • -</ul><h5>Plain radiograph</h5><p>In population-based studies, the sensitivity of chest radiography for detection of this disease is relatively low <sup>1</sup>. Many patients may indeed have normal radiographs <sup>3</sup>. </p><p>Abnormal plain radiographic findings may be observed in some patients can include <sup>3</sup></p><ul>
  • +</ul><h5>Plain radiograph</h5><p>In population-based studies, the sensitivity of <a title="Chest radiography" href="/articles/chest-radiograph">chest radiography</a> for detection of this disease is relatively low <sup>1</sup>. Many patients have normal radiographs <sup>3</sup>. </p><p>Abnormal plain radiographic findings may be observed in some patients can include <sup>3</sup></p><ul>
  • -<li>a pattern of fine reticulation may also occur</li>
  • +<li>a pattern of fine <a title="Reticulation" href="/articles/reticular-interstitial-pattern">reticulation</a> may also occur</li>
  • -<li>volume loss may occur: particularly in the upper lungs, and peribronchial thickening may be visible</li>
  • +<li>volume loss may occur: particularly in the upper lungs, and <a title="Peribronchial thickening" href="/articles/peribronchial-cuffing-1">peribronchial thickening</a> may be visible</li>
  • -<li>parenchyma: <a title="Ground glass" href="/articles/ground-glass-opacification-3">ground-glass opacity (GGO)</a>, <a title="Mosaic attenuation pattern in lung" href="/articles/mosaic-attenuation-pattern-in-lung">mosaic attenuation</a>
  • +<li>parenchyma: <a href="/articles/ground-glass-opacification-3">ground-glass opacity (GGO)</a>, <a href="/articles/mosaic-attenuation-pattern-in-lung">mosaic attenuation</a>
  • -<li>small airways: ill-defined <a title="Centrilobular nodules - lung" href="/articles/centrilobular-lung-nodules-1">centrilobular nodules</a>, <a title="Air trapping" href="/articles/air-trapping">air trapping</a>
  • +<li>small airways: ill-defined <a href="/articles/centrilobular-lung-nodules-1">centrilobular nodules</a>, <a href="/articles/air-trapping">air trapping</a>
  • -<li>parenchyma: uniform and subtle GGOs, <a title="Lung consolidation" href="/articles/air-space-opacification-1">airspace consolidation</a>, <a title="Lung cysts" href="/articles/pulmonary-cyst">pulmonary cysts</a>
  • +<li>parenchyma: uniform and subtle GGOs, <a href="/articles/air-space-opacification-1">airspace consolidation</a>, <a href="/articles/pulmonary-cyst">pulmonary cysts</a>
  • -<li>coarse reticulations with lung distortion +/- non-predominate <a title="Traction bronchiectasis" href="/articles/traction-bronchiectasis">traction bronchiectasis</a> and <a title="Honeycombing (lungs)" href="/articles/honeycombing-lungs">honeycombing</a>
  • +<li>coarse reticulations with lung distortion +/- non-predominate <a href="/articles/traction-bronchiectasis">traction bronchiectasis</a> and <a href="/articles/honeycombing-lungs">honeycombing</a>
  • -<li>mid-zone predominant</li>
  • -<li>relative lower zone sparing</li>
  • +<li>
  • +<a title="Mid zone" href="/articles/mid-zone">mid-zone</a> predominant</li>
  • +<li>relative <a title="Lower zone" href="/articles/lower-zone">lower zone</a> sparing</li>
  • -<li>mosaic attenuation, <a title="Head cheese sign (lungs)" href="/articles/head-cheese-sign-lungs">three-density pattern (head cheese sign)</a> and/or air trapping</li>
  • +<li>mosaic attenuation, <a href="/articles/head-cheese-sign-lungs">three-density pattern (head cheese sign)</a> and/or air trapping</li>
  • -<li><a title="Diagnostic HRCT criteria for usual interstitial pneumonia (UIP) pattern - ATS/ERS/JRS/ALAT (2018)" href="/articles/diagnostic-hrct-criteria-for-usual-interstitial-pneumonia-uip-pattern-atsersjrsalat-2018">usual interstitial pneumonia (UIP) pattern</a></li>
  • +<li><a href="/articles/diagnostic-hrct-criteria-for-usual-interstitial-pneumonia-uip-pattern-atsersjrsalat-2018">usual interstitial pneumonia (UIP) pattern</a></li>
  • -<li><a title="Fibrotic NSIP" href="/articles/fibrotic-non-specific-interstitial-pneumonitis">fibrotic non-specific interstitial pneumonia (NSIP) pattern</a></li>
  • +<li><a href="/articles/fibrotic-non-specific-interstitial-pneumonitis">fibrotic non-specific interstitial pneumonia (NSIP) pattern</a></li>
  • -<a title="Organising pneumonia" href="/articles/organising-pneumonia">organising pneumonia</a> <sup>14</sup>
  • +<a href="/articles/organising-pneumonia">organising pneumonia</a> <sup>14</sup>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.